Estrogen metabolites, as well as receptors and enzymes related to estrogen signaling pathways and associated conditions (such as BMPR2 mutations), contribute more specifically to the penetrance of PAH in females (28). Here, BMPR2 is linked to pulmonary arterial hypertension.